Pillstats
Rx only · Kit

Adalimumab-Afzb

Brands: Abrilada

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)327361
US makers2 labelers
Packages5
DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown4SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 9, 2025
    RESOLVEDShortage resolved: Adalimumab-afzb Injection (Pfizer Inc.)

    Adalimumab-afzb Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Rheumatology.

  • Oct 9, 2025
    SHORTAGEDrug shortage: Adalimumab-afzb Injection (Pfizer Inc.)

    Adalimumab-afzb Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Rheumatology.